التفاصيل البيبلوغرافية
| العنوان: |
Optimizing the Use of Glucagon-Like Peptide 1 Receptor Agonists in Type 2 Diabetes: Executive Summary. |
| المؤلفون: |
Anderson, John, Gavin III, James R., Kruger, Davida F., Miller, Eden |
| المصدر: |
Clinical Diabetes; Summer2022, Vol. 40 Issue 3, p265-269, 5p |
| مصطلحات موضوعية: |
PUBLIC health surveillance, INJECTIONS, TYPE 2 diabetes, DECISION making, GLUCAGON-like peptide-1 agonists, PATIENT education, VIDEO recording |
| الشركة/الكيان: |
AMERICAN Diabetes Association |
| مستخلص: |
The article discusses the type 2 diabetes treatment algorithm recommended by the American Diabetes Association (ADA) has undergone major changes in the past 5 years based on a greater understanding of the pathophysiology of diabetes and extensive investigation of the clinical profiles of glucose lowering medications (1,2). As a consequence, the glucagon- like peptide 1 (GLP-1) receptor agonists are now recommended in several clinical situations for people with type 2 diabetes (2). |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder